Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
 Regulatory Submissions, Information and Document Management Forum - EconoTimes)
ROCKVILLE, Md., Feb. 06, 2018 -- Dinocrates Group today announced its CTO, Jim St. Clair, delivered the keynote for the Drug Information Association’s (DIA) Forum on Regulatory Submissions, Information, and Document Management (RSIDM) in Bethesda, Md. St. Clair provided an insider’s perspective about the ways in which blockchain is being piloted for use in the drug information supply chain.
Blockchain has the potential to dramatically improve elements of the pharmaceutical supply chain by helping pharma companies and distributors improve security and traceability to cut down on the spread of counterfeit drugs. With barcode-tagged drugs scanned and entered into secure digital blocks whenever they change hands, an ongoing real-time record can be viewed anytime by authorized parties throughout the supply chain.
St. Clair, who founded the Institute for Healthcare Financial Technology, presented to a packed crowd of regulatory specialists on the use of blockchain to create immutable records of drug information transactions. As part of the presentation, he explained how using blockchain distributed ledgers can help facilitate compliance with the International Standards framework for the Identification of Medicinal Products (IDMP).
St. Clair is leading the effort to establish one of the first blockchain solutions labs for the public and life sciences sectors. The lab, known as ALEXANDER, will host demonstrable solutions and concepts to showcase blockchain applications for industry processes.
About Dinocrates Group
Dinocrates is a boutique strategy and technology advisory firm that is headquartered in Rockville, MD and partners with clients from the public and private sectors to identify their highest-value opportunities, addresses their most critical challenges, and transform their enterprises.
Contact: Ivy Eckerman Spire Communications for Dinocrates Group LLC (540) 373-2963 [email protected]
